TetraLogic Announces Termination of Public Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. PLTR
4. SPY
5. CSCO
6. KTOS
7. LBRX
8. BMY
9. MRK
10. TRAX

Go back to TetraLogic Announces Termination of Public Offering

TetraLogic Pharma (TLOG) to Resume Trading at 2:30

May 6, 2015 2:28 PM EDT

TetraLogic Pharma (NASDAQ: TLOG) to Resume Trading at 2:30

... More

TetraLogic Pharma (TLOG) Terminates Common Stock Offering

May 6, 2015 2:26 PM EDT

TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced termination of the underwriting agreement for and cancellation of its previously announced underwritten public offering of 6.25 million... More

Tetralogic (TLOG) PT Cut to $7 at Needham & Company After Halting Study; Maintains 'Buy'

May 6, 2015 2:08 PM EDT

Needham & Company analyst Chad Messer cut his price target on Tetralogic Pharmaceuticals (NASDAQ: TLOG) to $7.00 (from $10.00) after the comapny announced that it will temporarily halt enrollment multiple ascending dose chronic hepatitis B (HBV) trial of birinapant. However, the firm maintained a Buy... More